Salinas-Torres VM, Serra-Ruiz L, Cadena-González PJ, Angulo-Castellanos E

Language: Spanish
References: 14
Page: 224-229
PDF size: 135.32 Kb.

ABSTRACT

Introduction: Cocaine and alcohol are potentially teratogenic in human embryo development, craniofacial dysmorphic features in children with cocaine and alcohol embryopathy are well defined and the effects of both could be seen together in a prenatally exposed individual to these harmful substances. Case report: Mother of 33 years old with history of alcohol and cocaine consumption, during the last six years and all the gestational period (corroborated by self report and urinalysis). Male, newborn obtained via vaginal delivery at 35 weeks, because premature rupture of membranes. On the third day of life begun with rejection of oral feeding and irritability, during a period of 24 hours. Clinical examination found craneofacial dysmorphia, but other systems and organs were normal. The cocaine toxicological report in the urinalysis, was positive in the first 24 hours. Conclusions: We describe a case with craniofacial features consistent with prenatal cocaine and alcohol exposure. It is controversial whether the dysmorphic craniofacial features described were the product of independent or combined action of both teratogenic or just a coincidental finding. Further detailed observation and proper investigation is required in such cases in order to acquire more precise knowledge of which these pathologies are produced.

REFERENCES

1. Encuesta Nacional de Adicciones 2008 [homepage on the Internet]. Instituto Nacional de Salud Pública, México. [updated 2011 Sep 10]. Disponible en: http://insp.mx/images/stories/INSP/EncNacAdi/Docs/jalisco.pdf

2. Robin NH, Zackai EH. Unusual craniofacial dysmorphia due to prenatal alcohol and cocaine exposure. Teratology 1994; 50: 160-4.

3. Fries MH, Kuller JA, Norton ME, Yankowitz J, Kobori J, Good WV et al. Facial features of infants exposed prenatally to cocaine. Teratology 1993; 48: 413-20.

4. Clarren SK, Smith DW. The fetal alcohol syndrome. N Engl J Med 1978; 298: 1063-7.

5. Gorlin RJ, Cohen MMJr, Hennekam RCM. Alcohol embryopathy. In: Gorlin RJ, Cohen MMJr, Hennekam RCM, editors. Syndromes of the head and neck. 4th ed. Oxford: Oxford University Press 2001: 14-6.

6. Gorlin RJ, Cohen MMJr, Hennekam RCM. Cocaine embryopathy. In: Gorlin RJ, Cohen MMJr, Hennekam RCM, editors. Syndromes of the head and neck. 4th ed. Oxford: Oxford University Press 2001: 17-8.

7. Salinas-Torres VM, Aguirre-Jáuregui OM, Pérez-García G, Cadena-González PJ, Raya-Trigueros A, Gutiérrez-Padilla JA. Meromelia transversa en las cuatro extremidades con facie característica asociada al abuso de cocaína en el primer trimestre del embarazo. Bol Med Hosp Infant Mex “en prensa”.

8. Kashiwagi M, Chaoui R, Stallmach T, Hurlimann S, Lauper U, Hebisch G. Fetal bilateral renal agenesis, phocomelia, and single umbilical artery associated with cocaine abuse in early pregnancy. Birth Defects Research (Part A) 2003; 67: 951-2.

9. Hoyme HE, Jones KL, Dixon SD, Jewett T, Hanson JW, Robinson LK et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 1990; 85: 743-7.

10. Gutiérrez-Padilla JA, González-Garrido AA, Gómez-Velázquez FR, De la Torre-Gutiérrez M, Avalos-Huizar LM, García-Hernández H et al. Hijos de madres adictas con síndrome de abstinencia en terapia intensiva neonatal. Bol Med Hosp Infant Mex 2008; 65: 276-81.

11. Minnes S, Robin NH, Alt AA, Kirchner HL, Satayathum S, Salbert BA et al. Dysmorphic and anthropometric outcomes in 6-year-old prenatally cocaine-exposed children. Neurotoxicol Teratol 2006; 28: 28-38.

12. NOM-028-SSA2-1999, para la prevención, tratamiento y control de las adicciones [homepage on the Internet]. Secretaria de Salud, Estados Unidos Mexicanos. [updated 2011 Sep 10]. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/028ssa29.html

13. Addis A, Moretti ME, Syed FA, Einarson TR, Koren G. Fetal effects of cocaine: an update meta-analysis. Reprod Toxicol 2001; 15: 341-69.

14. Kuhn L, Kline J, Ng S, Levin B, Susser M. Cocaine use during pregnancy and intrauterine grow retardation: new insights based on maternal hair tests. Am J Epidemiol 2000; 152: 112-9.